OpenVSafe by OpenVAERS
Search V-safe

46K-60547-45531

2 vaccinations 2 coded responses 23 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
121 / NY
Registered
2022-07-12
Relationship
Child or adolescent in my care
Guardian
ZJL-27027-98577
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-12
    Registered in v-safe
  2. 2022-07-12
    Dose 1 — Pfizer-BioNTech
  3. 2022-07-12
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · Sleepiness, Irritability/crying
    Under 3 check-in
  4. 2022-07-13
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-14
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-15
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-16
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-17
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Teething — Feeling: Fair · Irritability/crying
    Free text: He is also teething.
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-07-18
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-19
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-07-26
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-02
    Dose 2 — Pfizer-BioNTech
  13. 2022-08-02
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-08-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Site: Groin or underarm swelling/tenderness · Sleepiness
    Under 3 check-in
  15. 2022-08-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-08-05
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-08-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-08-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-08-09
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-08-16
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-08-23
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-08-30
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-09-06
    Health check-in — day 35, dose 2, under 3
    Feeling: Poor
    Under 3 check-in
  25. 2022-11-01
    Survey response — 3 months, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-11-01
    Report sent to call center — 3 months, dose 2, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  27. 2022-11-02
  28. 2023-01-31
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-12Pfizer-BioNTech No
22022-08-02Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-11-01 Unsuccessful

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-07-17

Systemic reaction (other): He is also teething.

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-11-01

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory syncytial virus infection · · ✓
SROTeething · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…